Cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, biological analysis and molecular docking study of sulphur containing heterocyclic analogues

被引:4
|
作者
Ullah, Hayat [1 ]
Rahim, Fazal [2 ]
Uddin, Imad [3 ]
Taha, Muhammad [4 ]
Khan, Misbah Ullah [5 ]
Khan, Fahad [2 ]
Khan, Shoaib [6 ]
Hussain, Rafaqat [2 ]
Hussain, Amjad [1 ]
Iqbal, Naveed [7 ]
Gul, Farzana [8 ]
机构
[1] Univ Okara, Dept Chem, Okara 56130, Pakistan
[2] Hazara Univ, Dept Chem, Mansehra 21300, Khyber Pakhtunk, Pakistan
[3] Univ Haripur, Dept Chem, Haripur 22620, Khyber Pakhtunk, Pakistan
[4] Imam Abdulrahman Bin Faisal Univ, Inst Res & Med Consultat IRMC, Dept Clin Pharm, POB 1982, Dammam 31441, Saudi Arabia
[5] Univ Okara, Ctr Nanosci, Okara 56130, Pakistan
[6] Abbottabad Univ Sci & Technol AUST, Dept Chem, Abbottabad, Pakistan
[7] Univ Poonch, Dept Chem, Rawalakot, Ajk, Pakistan
[8] Hazara Univ, Dept Biochem, Mansehra 21300, Khyber Pakhtunk, Pakistan
来源
CHEMICAL DATA COLLECTIONS | 2024年 / 51卷
关键词
Synthesis; Thiophene; Sulfonamide; Acetylcholinesterase; Butyrylcholinesterase; GLUTATHIONE-S-TRANSFERASE; CARBONIC-ANHYDRASE; ACETYLCHOLINE ESTERASE; ALPHA-GLUCOSIDASE; DERIVATIVES; BUTYRYLCHOLINESTERASE; ANTIOXIDANT; LACTOPEROXIDASE; THIAZOLE; BASES;
D O I
10.1016/j.cdc.2024.101132
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In synthetic medicinal chemistry thiophene and their analogues play a vital role due to the wide range of pharmacological properties. In current studies, we have synthesized a new class of thiophene-bearing sulfonamide analogues (1-11) as cholinesterase inhibitors. These newly synthesized upon esterification, hydrazide formation and finally through sulfonamide mode of synthesis and were characterized through 1H, 13C NMR and HREI-MS spectroscopic techniques. Synthesized analogues showed an excellent to moderate cholinesterase inhibitory potential. Analogues 10, 7, 9 and 11 showed an excellent potency against cholinesterase inhibition as compared to standard Donepezil. The binding interactions of the most potent analogues were confirmed through molecular docking studies. All Compounds were verified for cytotoxicity against 3T3 mouse fibroblast cell line and detected non-toxic.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Dual inhibitors of Interleukin-6 and acetylcholinesterase for treatment of Alzheimer's disease: Design, docking, synthesis and biological evaluation
    Kaur, Sukhvir
    Bansal, Yogita
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2021, 98 (10)
  • [42] Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study
    Homoud, Zahra Abdulkarim
    Taha, Muhammad
    Rahim, Fazal
    Iqbal, Naveed
    Nawaz, Muhammad
    Farooq, Rai Khalid
    Wadood, Abdul
    Alomari, Munther
    Islam, Imadul
    Algheribe, Shatha
    Rehman, Ashfaq Ur
    Khan, Khalid Mohammed
    Uddin, Nizam
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (19): : 9865 - 9878
  • [43] Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors
    Yoon, Yeong Keng
    Ali, Mohamed Ashraf
    Wei, Ang Chee
    Choon, Tan Soo
    Khaw, Kooi-Yeong
    Murugaiyah, Vikneswaran
    Osman, Hasnah
    Masand, Vijay H.
    BIOORGANIC CHEMISTRY, 2013, 49 : 33 - 39
  • [44] New cholinesterase inhibitors for Alzheimer's disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives
    Bacalhau, Patricia
    Juan, Amor A. San
    Marques, Carolina S.
    Peixoto, Daniela
    Goth, Albertino
    Guarda, Catia
    Silva, Mara
    Arantes, Silvia
    Teresa Caldeira, A.
    Martins, Rosario
    Burke, Anthony J.
    BIOORGANIC CHEMISTRY, 2016, 67 : 1 - 8
  • [45] Utility of an Effect Size Analysis for Communicating Treatment Effectiveness: A Case Study of Cholinesterase Inhibitors for Alzheimer's Disease
    Peters, Kevin R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (07) : 1170 - 1174
  • [46] Multifunctional cholinesterase inhibitors for Alzheimer's disease: Synthesis, biological evaluations, and docking studies of o/p-propoxyphenylsubstituted-1H-benzimidazole derivatives
    Sarikaya, Gorkem
    Coban, Gunes
    Parlar, Sulunay
    Tarikogullari, Ayse H.
    Armagan, Guliz
    Erdogan, Mumin A.
    Alptuzun, Vildan
    Alpan, Ayse S.
    ARCHIV DER PHARMAZIE, 2018, 351 (08)
  • [47] Beyond TacrineRecently Developed Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
    Latha K. Unni
    CNS Drugs, 1998, 10 : 447 - 460
  • [49] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
    Parsons, Chris G.
    Danysz, Wojciech
    Dekundy, Andrzej
    Pulte, Irena
    NEUROTOXICITY RESEARCH, 2013, 24 (03) : 358 - 369
  • [50] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Rabins, Peter V.
    Lyketsos, Constantine G.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (11): : 578 - 579